View contact record, Full name: Cristina Terlizzi
CNR Ibb | back to homepage
CNR Ibb | back to homepage
Advanced search▼
Staff: advanced search.
Query:
Options:       Extended  
Role or Position:
Working site:
Photo
NameCristina Terlizzi
AreaResearch&Development
PositionTemporary Technologist
Work siteNaples - De Amicis
AddressVia De Amicis 95, 80145 Naples - Italy
E-mailcristina.terlizzicnr.it
No research areas
No activities
Empty curriculum
Filter those results▼
Bibliography: advanced search.
Query:  [X]
Options:
   Extended  
   IBB affiliation
 
Authors:  [X]
Paper type:  [X]
Start date:  [X]
End date:  [X]
 
[Clear form]
Select the year: 
Filters: Author filter: Terlizzi C  
Sort by:   date ▼▲   title ▲ ▼   journal ▲ ▼   authors ▲ ▼   I.F. ▲ ▼
* ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors (43 views)
Terlizzi C, De Rosa V, Iommelli F, Pezone A, Altobelli GG, Maddalena M, Dimitrov J, De Rosa C, Della Corte CM, Avvedimento VE, Del Vecchio S
Cancer Metab (ISSN: 2049-3002linking), 2023 Nov 6; 11(1): 20-20.
Impact Factor: 5.9
View    Export to BibTeX    Export to EndNote

* Non-Canonical Role of PDK1 as a Negative Regulator of Apoptosis through Macromolecular Complexes Assembly at the ER-Mitochondria Interface in Oncogene-Driven NSCLC (55 views)
De Rosa V, Iommelli F, Terlizzi C, Leggiero E, Camerlingo R, Altobelli GG, Fonti R, Pastore L, Del Vecchio S
Cancers (ISSN: 2072-6694linking), 2021 Aug 17; 13 (16 ): N/D-N/D.
Impact Factor: 6.126
View    Export to BibTeX    Export to EndNote

* A Reversible Shift of Driver Dependence from EGFR to Notch1 in Non-Small Cell Lung Cancer as a Cause of Resistance to Tyrosine Kinase Inhibitors (95 views)
Iommelli F, De Rosa V, Terlizzi C, Fonti R, Camerlingo R, Stoppelli MP, Stewart CA, Byers LA, Piwnica-worms D, Del Vecchio S
Cancers (ISSN: 2072-6694linking), 2021 Apr 22; 13(9): N/D-N/D.
Impact Factor: 6.126
View    Export to BibTeX    Export to EndNote

* Preclinical imaging for targeting cancer immune evasion (95 views)
Terlizzi C, De Rosa V, Iommelli F, Altobelli GG, Fonti R, Del Vecchio S
Q J Nucl Med Mol Im (ISSN: 1824-4785linking, 1824-4478, 1827-1936), 2020 Jun; 64(2): 186-193.
Impact Factor: 1.795
View    Export to BibTeX    Export to EndNote

* Preclinical Imaging in Targeted Cancer Therapies (340 views)
Iommelli F, De Rosa V, Terlizzi C, Fonti R, Del Vecchio S
Semin Nucl Med (ISSN: 0001-2998linking), 2019 Sep; 49(5): 369-381.
Impact Factor: 3.798
View    Export to BibTeX    Export to EndNote

* Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells (429 views)
De Rosa V, Monti M, Terlizzi C, Fonti R, Del Vecchio S, Iommelli F
Int J Mol Sc (ISSN: 1422-0067linking, 1661-6596, 1422-0067electronic), 2019 Jun 27; 20(13): N/D-N/D.
Impact Factor: 4.183
View    Export to BibTeX    Export to EndNote

* Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins (394 views)
Monti M, De Rosa V, Iommelli F, Carriero MV, Terlizzi C, Camerlingo R, Belli S, Fonti R, Di Minno G, Del Vecchio S
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2018 Aug 9; 19(8): N/D-N/D.
Impact Factor: 3.687
View    Export to BibTeX    Export to EndNote

* Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by (18)F-fluorothymidine (689 views)
Iommelli F, De Rosa V, Terlizzi C, Monti M, Panico M, Fonti R, Del Vecchio S
Clin Cancer Res (ISSN: 1078-0432print, 1078-0432linking), 2018 Jul 1; 24(13): 3126-3136.
Impact Factor: 10.199
View    Export to BibTeX    Export to EndNote

* Preclinical imaging in oncology: advances and perspectives (397 views)
Iommelli F, De Rosa V, Terlizzi C, Del Vecchio S
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1827-1936), 2016 Nov 18; 61(1): 33-47.
Impact Factor: 2.481
View    Export to BibTeX    Export to EndNote

9 Records (9 excluding Abstracts).
Total impact factor: 44.295 (44.295 excluding Abstracts).
Total 5 year impact factor: 22.292 (22.292 excluding Abstracts).

Last modified by Massimiliano Sorbillo on Thursday 23 November 2023, 18:29:13
57 views. Last view on Thursday 12 September 2024, 11:26:57